Cargando…
Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment
Autores principales: | Hoffmann, Markus, Jin, Yeonhwa, Pöhlmann, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436721/ https://www.ncbi.nlm.nih.gov/pubmed/36050376 http://dx.doi.org/10.1038/s41422-022-00713-y |
Ejemplares similares
-
Dalbavancin: novel candidate for COVID-19 treatment
por: Hoffmann, Markus, et al.
Publicado: (2021) -
Correction to: A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing
por: Díaz-Navarro, Marta, et al.
Publicado: (2022) -
Dalbavancin
por: Barberán, José, et al.
Publicado: (2021) -
Dalbavancin: a novel antimicrobial
por: Chen, A Y, et al.
Publicado: (2007) -
Publisher Correction: COVID-19 antibodies on trial
por: DeFrancesco, Laura
Publicado: (2021)